HOME | CONTACT | BLOG | SITE MAP   

Press Releases

VetStem Biopharma and PALL Life Sciences announce a clinical research/technology distribution agreement for Pall's Veterinary Platelet Enhancement Therapy system V-PET

VetStem Biopharma and PALL Life Sciences announce a clinical research and technology distribution agreement for Pall's unique filtration based Veterinary Platelet Enhancement Therapy System V-PET

November 15, 2015 --

"VetStem was a logical choice, given that they are the stem cell leader in the US and Canadian markets. We share a commitment to ongoing research in the life science fields.", stated Mr. Antoine, Pall Sales Manager, Americas Cell Therapy.

 

 

"The V-PET™ platelet enhancement therapy system complements perfectly our current portfolio of regenerative medicine solutions", said Dr Nahama, President and Chief Commercial Officer for VetStem. "It is validated for use in dogs and horses. Because the technology is gravity filtration based, it does not require a centrifuge to process samples. Any veterinarian in the field, at the patients’ home or in a hospital setting can have enhanced platelet therapy ready for injection in about 30 minutes."

 

 

"Stem Cell Therapy and enhanced platelet therapy are highly complementary depending on the disease state and the specific client needs", added Dr Nahama.

 

 

Platelet therapy promotes healing when the body requires help to kick start its natural internal repair processes. Platelets contain a variety of growth factors that, once released, attract progenitor cells, enhance wound healing and stimulate tissue regeneration. Since the animal is the donor and recipient of the therapy, the safety profile (autologous therapy) is very favorable.

 

 

The most common uses of platelet therapy are for indications such as hard to heal wounds, tendon and ligament injuries, as well as joint disease (osteoarthritis).

 

 

V-PET™ will be available to US and Canada veterinarians directly through VetStem Biopharma, or selected distributors, starting late November 2015.

 

 

 

 

About PALL Life Sciences
Pall Corporation is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industrial manufacturing. Pall works with customers to advance health, safety and environmentally responsible technologies. The Company’s engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation serves customers worldwide. For more information, please visit: http://www.pall.com, or follow us on social media at: Facebook; Google+; LinkedIn ; Twitter; and YouTube.

 

 

 

Contact
Mary-Shea Rozsypal
Director, Global Marketing Communications
Pall Life Sciences
Email: Mary-Shea_Rozsypal@pall.com





< Back to Press Releases     

 


  • Success Stories
    News
    Videos
    Blog
    Press Releases
    Facebook
    Twitter
     


      COMPANY
    Management
    Investors
    Contact Us
    Careers
    Privacy Policy
    SCIENCE
    FAQs
    Literature Refs
    Safety
    PET & HORSE OWNERS
    Dogs & Cats
    Horses
    Locate a Vet
    FAQs
    VETERINARIANS
    Vet Login /
    Credentialing

    Dogs & Cats
    Horses
    FAQs
    MEDIA ROOM
    Press Releases
    Success Stories
    News
    Videos
    Blog
    LOCATE A VET

    CONTACT US
     

    COPYRIGHT 2011 VETSTEM BIOPHARMA. ALL RIGHTS RESERVED.
    12860 Danielson Court, Suite B, Poway, CA 92064 Phone: 858-748-2004 or 888-387-8361